top of page

Search


Gore Range Capital Announces Inaugural Fund III Investment in Obagi Medical
Investment alongside Bridgepoint marks the first investment from Gore Range Fund III and builds on the firm's longstanding focus on skin health and medical aesthetics
Gore Range Capital
Aug 18


Skin Health at the Front of Longevity
Is healthy skin a key to long life? Longevity medicine is undergoing a profound transformation.
Humberto Antunes
Jun 9


Join Gore Range at The Summit
In addition to serving as a member of the Dermatology Summit's Conference Board of Directors & Advisors , Gore Range Capital's Humberto Antunes will serve as moderator twice during the Dermatology Summit in San Francisco on January 11, 2026. Join Humberto as he guides the industry's top voices through popular topics challenging the skin health market today. We look forward to seeing you there! Introducing a brand new session! “The Now and Future of the Dermatology Business
Gore Range Capital
Jan 7


Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast
Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio Obagi Medical is an...
Gore Range Capital
Jul 23, 2025


Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results
Demonstrates Potential for ET-02 to be Significantly More Effective Than Existing Treatments for Hair Loss
Press Release
Jan 8, 2025


Ethan Rigel talks Launching A Venture Fund with Smart Business Dealmakers Podcast
Standing Out In A Pool Of Gray, Ep. 283
Smart Business Dealmakers
Dec 23, 2024


Palvella Therapeutics Awarded Up to $2.6 million Grant from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development
Palvella Therapeutics Awarded Up to $2.6 million Grant
Press Release
Oct 3, 2024


Sagesse Bio Accelerates Development of SGY-101 into clinical development for Targeted Fat Reduction in Aesthetic Medicine and Medical Dermatology
Sagesse Bio partners with industry leaders to advance SGY-101, a novel siRNA therapeutic for focal fat reduction and tissue remodeling,...
Gore Range Capital
Aug 15, 2024


Gore Range Capital Partners with Sirnaomics to Create Sagesse Bio to Advance RNAi Therapeutics for Focal Fat Reduction and Aesthetic Body Contouring
Strategic partnership to advance innovative RNAi therapeutics for focal fat reduction and aesthetic body contouring Sagesse Bio combines...
Gore Range Capital
Aug 5, 2024


Avive Solutions Raises $56.5M
Avive Solutions Raises $56.5M in Growth Funding To Build Connected AED Network and Transform Cardiac Arrest Emergency Response in...
Press Release
Apr 18, 2024


Dr. Balaji Jothishankar Joins Gore Range Capital as Entrepreneur in Residence
Dr. Balaji Jothishankar MD, MBA, has joined Gore Range Capital as Entrepreneur in Residence. Dr. Jothishankar brings a wealth of...
Gore Range Capital
Feb 8, 2024


Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market
SOUTHLAKE, Texas, Jan. 8, 2024 /PRNewswire/ -- Novaestiq Corp., a growth-oriented aesthetic and medical dermatological innovations...
Press Release
Jan 8, 2024
bottom of page
